Doctor Philip D Adamson
University of Otago Christchurch, Christchurch (New Zealand)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dual antiplatelet therapy to inhibit myocardial injury in patients with high-risk coronary artery plaque: a randomized controlled trial
Event: ESC Congress 2019
Topic: Positron Emission Tomography (PET)
Session: Blockbusters from the Young - Multimodality Imaging in coronary artery disease
Impact of international guidelines' differing approaches to the risk stratification of patients with suspected stable angina: Insights form PROMISE and SCOT-HEART
Event: ESC Congress 2018
Topic: Clinical, Other
Session: Latest registry data on coronary disease outcomes
Prognostic value of convalescent high-sensitivity troponin I concentrations following acute coronary syndrome
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Cardiac troponins: starting levels and outcomes
Diagnostic and prognostic benefits of CTCA using the updated NICE guidance: An analysis of the Scottish computed tomography of the heart (SCOT-HEART) trial
Event: ESC Congress 2017
Topic: Angina pectoris stable
Session: Young Investigator Awards Session Population Sciences
ESC 365 is supported by
